Revenue and Growth
Third quarter revenue of $104.6 million, representing 10% reported year-over-year growth. Adjusted EBITDA of $35.2 million with a margin of 34%.
Software Segment Performance
Software revenue of $43.8 million grew 22% on a reported basis, with 6% organic growth. Software bookings increased by 17%.
R&D Investment Increase
R&D spending increased by 24% over the same period last year and now accounts for 10% of revenue, up from 9%.
New Product Launches
Launched major products including Pinnacle 21 Enterprise, Phoenix Cloud, and CertaraIQ, with positive early customer feedback.
Chemaxon Acquisition Success
Chemaxon contributed $5.6 million to revenue, on track to reach corporate average margins by year-end.